期刊文献+

谷氨酰胺对肝硬化大鼠肠屏障功能的保护作用 被引量:5

Protective effects of glutamine on intestinal barrier in rats with liver cirrhosis
下载PDF
导出
摘要 目的观察谷氨酰胺对肝硬化大鼠肠屏障功能是否具有保护作用。方法采用CCL4+酒精制备大鼠肝硬化模型。30只Wistar大鼠随机分为正常对照组,肝硬化模型对照组及谷氨酰胺治疗组。使用苏木素-伊红(HE)、胶原纤维(VG)染色以及电镜技术从形态学上检测谷氨酰胺对肝硬化程度以及肠功能屏障障碍的改善状况,采用血浆二胺氧化酶和血浆内毒素水平检测各干预组的疗效。结果 VG染色显示谷氨酰胺治疗组肝纤维化程度减轻;HE、电镜结果显示谷氨酰胺治疗组肠屏障结构损伤减轻;门静脉内毒素水平及血浆二胺氧化酶(DAO)水平在肝硬化模型组均显著高于正常对照组(P<0.05),谷氨酰胺治疗组两指标水平均低于同期肝硬化模型组(P<0.05)。结论谷氨酰胺对肝硬化大鼠肠屏障功能具有保护作用。 Objective To determine the protective effects of glutamine on intestinal barrier in rats with liver cirrhosis. Methods Following establishment of the liver cirrhosis model induced by carbon tetrachloride and alco- hol, 30 Wistar rats were randomly assigned to normal control, liver cirrhosis model control and glutamine treatment group, respectively. The amelioration in liver cirrhosis and intestinal barrier dysfunction following administration of glutamine was assessed by HE and VG staining and electron microscopy. The levels of plasma diamine oxidase and endotoxin were employed to evaluate the efficacy in respective group. Results It has been evidenced by VG staining that glutamine treatment group was characterized of mostly attenuated liver fibrosis and by HE staining and electron microscopy that intestinal barrier dysfunction was reduced. Higher level of portal vein endotoxin and plasma DAO was noted in cirrhosis model group normal, but not in control group (P〈0.05). Conclusion Glutamine plays a protective role on the intestinal barrier in rats with liver cirrhosis. Furthermore, the two indicators in treatment group were lower than those in cirrhosis model group at the same period (P〈0.05).
出处 《中国药物与临床》 CAS 2013年第3期305-307,I0002,共4页 Chinese Remedies & Clinics
基金 山西医科大学第一医院青年基金(05028A)
关键词 谷氨酰胺 肝硬化 大鼠 肠屏障 Glutamine Liver cirrhosis Rats Intestinal barrier
  • 相关文献

参考文献16

  • 1MacFie J. Enteral versus parenteral nutrition: the significance of bacterial translocation and gut--barrier function. Nutrition, 2000,16(7-8) :606-610.
  • 2Van der Hulst RR,von Meyenfeldt MF,van Kreel BK,et al. Gut permeability, Intestinal morphology, and Nutritional depletion. Nutrition, 1998,14( 1 ) : 1-6.
  • 3Saadia R,Schein M,MacFarlane C,et al. Gut barrier fution and the surgeon. Br J Surg, 1990,77:487.
  • 4韩德五.肠源性内毒素血症所致“继发性肝损伤”的临床依据[J].世界华人消化杂志,1999,7(12):1055-1058. 被引量:53
  • 5Young VR,Ajami AM. Glutamine: the emperor or his clothes. J Nutr,2001,131 (9) :2449-2459.
  • 6Coeffier M, Dechelote P. The role of glutamine in intensive care unit patients : mechanisms of action and clinical outcome. Nutr Rev,2005,63(2) :65-69.
  • 7Soderholm JD,Perdue MH. Stress and gastrointestinal tract II. Stress and the intestinal barrier function. Am J Physiol Gastroin- test Liver Physiol,2001,280(1 ) :7-13.
  • 8韩德五,马学惠,赵元昌肝硬化动物模型的研究.山西医药杂志,1979,8(4):1.
  • 9黎君友,吕艺,薛丽波,王淑英,陆江阳,胡森,田惠民,盛志勇.烫伤大鼠小肠组织和血二胺氧化酶活性的变化[J].中国应用生理学杂志,1993,9(4):355-356. 被引量:7
  • 10陈渝萍,钟转华,梁月环,王安.微生态制剂对肝硬化患者肠屏障功能影响及疗效观察[J].临床消化病杂志,2010,22(4):204-207. 被引量:25

二级参考文献80

共引文献105

同被引文献51

引证文献5

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部